Escucha el podcast EHA Unplugged

AIDPATH – AI automated CAR T-cell manufacturing (with Dr Carmen Sanges)	EHA Unplugged	20:57
Hematology Portraits: prof. Elizabeth Macintyre	EHA Unplugged	24:55
Is low-risk MDS really low risk? (with Prof Uwe Platzbecker)	EHA Unplugged	26:38
MRD Monitoring in MDS Patients (with Prof Arjan van de Loosdrecht)	EHA Unplugged	29:50
Hematology Portraits: prof. Martin Dreyling	EHA Unplugged	23:31
MDS Pathophysiology and the Role of Immune Dysfunction (with Dr Shahram Kordasti)	EHA Unplugged	22:53
Mapping Rare Anemia Patient Data: RADeep (with Dr. María del Mar Mañú Pereira)	EHA Unplugged	29:41
Hematology Portraits: prof. Antonio Almeida	EHA Unplugged	19:30
Targeting the Immune System in MDS (featuring Prof Dominik Wolf)	EHA Unplugged	24:13
Accelerating Clinical Trials with AI (with Dr Jan Moritz Middeke)	EHA Unplugged	16:44
The Current Diagnostic Approach to MDS (with Dr Onima Chowdhury)	EHA Unplugged	35:57
Hematology Portraits: Prof Brian Huntly	EHA Unplugged	29:46
Mental Health in CLL	EHA Unplugged	24:54
Patient Perspectives on Gene Therapy for Sickle Cell Disease and B-Thalassemia	EHA Unplugged	27:41
Hematology Portraits: Prof Kostas Stamatopoulos	EHA Unplugged	23:34
Management of High-risk MDS: Seeking Clarity for Classification and Treatment	EHA Unplugged	34:31
Hematopoietic Stem Cells in Health, Aging and Malignancy: Focus on Metabolism (EHA2024)	EHA Unplugged	07:37
Innovative Trial Design (EHA2024)	EHA Unplugged	17:31
Hereditary Hematological Malignancies (HHMs): A New Era of Discovery in MDS and AML (EHA2024)	EHA Unplugged	22:44
Hairy Cell Leukemia (HCL): Treatment of Relapsed Disease (EHA2024)	EHA Unplugged	17:41
Iron Metabolism in Myelodysplastic Syndrome (MDS)	EHA Unplugged	33:18
First-line Treatment of Primary Central Nervous System Lymphoma (PCNSL) (EHA2024)	EHA Unplugged	18:22
Optimizing Global Care for Women with von Willebrand Disease (VWD) (EHA2024)	EHA Unplugged	22:23
Iron and Infections: Back to the Future (EHA2024)	EHA Unplugged	17:46
Long-term Outcomes in the Chemo-free era for Acute Promyelocytic Leukemia (EHA2024)	EHA Unplugged	19:09
Thrombotic thrombocytopenic purpura (TTP): Is plasmapheresis history?	EHA Unplugged	17:19
The Role of Artificial Intelligence in Hematology (featuring Dr Gregor Hormann)	EHA Unplugged	16:20
From MDS to AML: Genetics of Progression (featuring Prof Lars Bullinger)	EHA Unplugged	20:33
Screening for Sickle Cell Disease (with Prof David Rees)	EHA Unplugged	17:50
The Environmental Impact on Hematology Practice (with Dr Stephen Hibbs)	EHA Unplugged	12:58
Synthetic Patients: The Future of Clinical Trials?	EHA Unplugged	14:45
Innovative tools for Disease Monitoring in Multiple Myeloma	EHA Unplugged	18:15
Hematology Portraits: Prof Ivo Touw	EHA Unplugged	28:13
Preventing Venous Thromboembolism (VTE) in Pregnant Women	EHA Unplugged	15:42
Gene Therapy for Hemophilia	EHA Unplugged	24:47
AI-driven Morphology in Hematology	EHA Unplugged	13:23
Regulatory Landscape for CAR T-cell Therapy	EHA Unplugged	11:07
Point-of-care CAR T-cell Manufacturing	EHA Unplugged	21:38
Processes in CAR T-cell Therapy	EHA Unplugged	27:44
CAR T-cell Therapy for Children with ALL	EHA Unplugged	18:51

AIDPATH – AI automated CAR T-cell manufacturing (with Dr Carmen Sanges)

EHA Unplugged

20:57

Hematology Portraits: prof. Elizabeth Macintyre

EHA Unplugged

24:55

Is low-risk MDS really low risk? (with Prof Uwe Platzbecker)

EHA Unplugged

26:38

MRD Monitoring in MDS Patients (with Prof Arjan van de Loosdrecht)

EHA Unplugged

29:50